ESC 24: Day 2 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Join Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful series of wrap-ups from the ESC Congress 2024 in London.
Trials covered in detail include:
NOTION-3
RHEIA
POPular PAUSE TAVI
MATTERHORN
RESHAPE-HF2
TRI.Fr
ASSURE DES
SWEDEGRAFT
Watch the Day 1 ESC 24 wrap-up from Dr Alasnag and Dr Al-Shaibi here.
Recorded on-site at the ESC Congress 2024, London.
Visit Radcliffe Cardiology: www.radcliffec...
Visit Radcliffe Vascular: www.radcliffev...
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on X: x.com/radcliff...

[@kingsleyihe5500]

Most interesting is the advantage of TAVR with PCI in the current study vs TAVR alone......as compared to the previous studies which surprisingly did not show any difference.......this shows that as per patho physiology the arteries of the periphery , aorta (with valve ) coronary and carotid branches behave in some similar ways....so when one is affected there's a likely chance that the others maybe affected with varying degrees